Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Total 13F shares
-
281,585,235
-
Share change
-
-652,487
-
Total reported value
-
$4,247,304,450
-
Put/Call ratio
-
11%
-
Price per share
-
$15.08
-
Number of holders
-
217
-
Value change
-
+$7,015,222
-
Number of buys
-
114
-
Number of sells
-
87
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2020
As of 30 Jun 2020 AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) had 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 281,585,235 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, Avoro Capital Advisors LLC, STATE STREET CORP, MORGAN STANLEY, JPMORGAN CHASE & CO, and FMR LLC.
This table shows 217 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.